[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Page 7717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02208]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE24-011, Grants To Support New Investigators in 
Conducting Research Related To Understanding Drug Use and Overdose Risk 
and Protective Factors (K01); Cancellation of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, 
Centers for Disease Control and Prevention, 4770 Buford Highway NE, 
Mailstop S106-9, Atlanta, Georgia 30341-3717. Telephone: (404) 639-
6473; Email: [email protected].

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP)--CE24-011, Grants to Support New 
Investigators in Conducting Research Related to Understanding Drug Use 
and Overdose Risk and Protective Factors (K01); Cancellation of 
Meeting; March 5, 2024, 8:30 a.m.-5 p.m., EST., in the original Federal 
Register notice FRN. The web conference was published in the Federal 
Register on Tuesday, October 24, 2023, 88 FR 73020.
    This meeting is being canceled in its entirety.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02208 Filed 2-2-24; 8:45 am]
BILLING CODE 4163-18-P